Emmaus Life Sciences, Inc. financial data

Symbol
EMMA on OTC
Location
21250 Hawthorne Boulevard, Suite 800, Torrance, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 10.5 % -30.8%
Quick Ratio 2.35 % -9.93%
Debt-to-equity -143 % +16.3%
Return On Assets -14 % +8.08%
Operating Margin -7.76 % -98.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 63.9M shares 0%
Common Stock, Shares, Outstanding 63.9M shares 0%
Entity Public Float 4.08M USD -54%
Common Stock, Value, Issued 64K USD 0%
Weighted Average Number of Shares Outstanding, Basic 63.9M shares +0.81%
Weighted Average Number of Shares Outstanding, Diluted 63.9M shares +0.81%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 14M USD -29.9%
Cost of Revenue 1.08M USD +19.4%
Research and Development Expense 515K USD -46%
Selling and Marketing Expense 3.75M USD -49%
General and Administrative Expense 9.73M USD -15.6%
Operating Income (Loss) -1.09M USD -39.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.97M USD +25.2%
Income Tax Expense (Benefit) -581K USD -1062%
Net Income (Loss) Attributable to Parent -3.39M USD +35.6%
Earnings Per Share, Basic 0 USD/shares +14.3%
Earnings Per Share, Diluted 0 USD/shares +14.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 886K USD -41.9%
Accounts Receivable, after Allowance for Credit Loss, Current 2.07M USD -55%
Inventory, Net 1.31M USD -19.3%
Other Assets, Current 220K USD -66.4%
Assets, Current 5.02M USD -44.4%
Property, Plant and Equipment, Net 143K USD +165%
Operating Lease, Right-of-Use Asset 830K USD -56.4%
Other Assets, Noncurrent 168K USD -45.5%
Assets 23.3M USD -10%
Accounts Payable, Current 4.56M USD -36.8%
Accrued Liabilities, Current 9.03M USD +10.6%
Liabilities, Current 62.1M USD -3.04%
Operating Lease, Liability, Noncurrent 1.58M USD +19.8%
Other Liabilities, Noncurrent 13.1M USD -14.6%
Liabilities 79M USD -4.71%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1.24M USD
Retained Earnings (Accumulated Deficit) -266M USD -1.29%
Stockholders' Equity Attributable to Parent -55.7M USD +2.3%
Liabilities and Equity 23.3M USD -10%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 279K USD +99.3%
Net Cash Provided by (Used in) Financing Activities -345K USD +63.9%
Net Cash Provided by (Used in) Investing Activities -4K USD +99.6%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 63.9M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -56K USD +93.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 415K USD -52.5%
Deferred Tax Assets, Valuation Allowance 38.8M USD -9.46%
Deferred Tax Assets, Gross 39.3M USD -9.37%
Operating Lease, Liability 1.9M USD -14.6%
Depreciation 19K USD -26.9%
Payments to Acquire Property, Plant, and Equipment 4K USD -33.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 1.25M USD
Lessee, Operating Lease, Liability, to be Paid 2.45M USD -3.28%
Property, Plant and Equipment, Gross 509K USD -2.86%
Operating Lease, Liability, Current 348K USD -61.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 506K USD -40.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 510K USD -54.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure -15.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 517K USD +68.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 513K USD
Deferred Tax Assets, Operating Loss Carryforwards 19.5M USD +10.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 15M shares 0%
Unrecognized Tax Benefits 0 USD
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) -603K USD -609%
Current Federal Tax Expense (Benefit) 0 USD
Depreciation, Depletion and Amortization 5K USD -16.7%
Deferred Tax Assets, Net of Valuation Allowance 426K USD -0.23%
Interest Expense 5.55M USD -20.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%